Post-approval studies (Phase 4)Ended earlyNCT01512472What this trial is testingFirmagon (Degarelix) Intermittent TherapyWho this might be right forProstate Cancer Recurrent Canadian Urology Research Consortium 144
Testing effectiveness (Phase 2)Active Not RecruitingNCT01786265What this trial is testingFinite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate CancerWho this might be right forProstate AdenocarcinomaRecurrent Prostate Carcinoma M.D. Anderson Cancer Center 310
Large-scale testing (Phase 3)Study completedNCT02081300What this trial is testingSafety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or HypogonadismWho this might be right forMale Hypogonadism Lipocine Inc. 315
Not applicableStudy completedNCT01366053What this trial is testingHormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH AgonistsWho this might be right forProstate Cancer CMX Research 125
Very early researchStudy completedNCT03004534What this trial is testingEvaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of DarolutamideWho this might be right forBreast Cancer Female Translational Research in Oncology 36
Very early researchStudy completedNCT03507608What this trial is testingAssessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen SuppressionWho this might be right forProstate Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03753334What this trial is testingEffects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.Who this might be right forProstate Cancer CHU de Quebec-Universite Laval 39
Testing effectiveness (Phase 2)Looking for participantsNCT06992232What this trial is testingRadiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPCWho this might be right forProstate Cancer Metastatic Disease The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 144
Testing effectiveness (Phase 2)Study completedNCT01750398What this trial is testingBipolar Androgen-based Therapy for Prostate Cancer (BAT)Who this might be right forRecurrent Prostate Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33
Not applicableLooking for participantsNCT07032584What this trial is testingImpact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate CancerWho this might be right forProstate CancerMetastatic Prostate CancerAndrogen Deprivation Therapy University of Utah 74
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07224009What this trial is testingLow Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)Who this might be right forMetastatic Prostate Cancer University of Arkansas 60
Early research (Phase 1)Study completedNCT02064036What this trial is testingStereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the ProstateWho this might be right forAdenocarcinoma of the Prostate University of California, Davis 17
Testing effectiveness (Phase 2)Study completedNCT01946165What this trial is testingAbiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and EnzalutamideWho this might be right forProstate Cancer M.D. Anderson Cancer Center 69
Not applicableLooking for participantsNCT07463092What this trial is testingCreatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation TherapyWho this might be right forProstate CancerSarcopenia University of Sao Paulo 34
Not applicableActive Not RecruitingNCT05901649What this trial is testingThe Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or EnzalutamideWho this might be right forMetastatic Hormone-sensitive Prostate Cancer Janssen-Cilag Ltd. 504
Not applicableStudy completedNCT00853164What this trial is testingA Pilot Study of Physical Activity for Improving Quality of Life in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)Who this might be right forProstate Cancer Washington University School of Medicine 8
Testing effectiveness (Phase 2)Study completedNCT01409200What this trial is testingAntiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node MetastasisWho this might be right forMetastatic Malignant Neoplasm in Lymph NodeProstate Ductal AdenocarcinomaStage III Prostate Adenocarcinoma AJCC v7+1 more M.D. Anderson Cancer Center 73
Post-approval studies (Phase 4)Study completedNCT00286364What this trial is testingShort-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled TrialWho this might be right forInfertility Rigshospitalet, Denmark
Large-scale testing (Phase 3)UnknownNCT00479609What this trial is testingTestosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 DiabetesWho this might be right forMetabolic Syndrome Karolinska Institutet 176
Testing effectiveness (Phase 2)Active Not RecruitingNCT06734130What this trial is testingAdaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate CancerWho this might be right forMetastatic Castration Sensitive Prostate Cancer H. Lee Moffitt Cancer Center and Research Institute 25